These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24036252)

  • 1. Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.
    Storci G; Bertoni S; De Carolis S; Papi A; Nati M; Ceccarelli C; Pirazzini C; Garagnani P; Ferrarini A; Buson G; Delledonne M; Fiorentino M; Capizzi E; Gruppioni E; Taffurelli M; Santini D; Franceschi C; Bandini G; Bonifazi F; Bonafé M
    Am J Pathol; 2013 Nov; 183(5):1688-1697. PubMed ID: 24036252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
    Chang CJ; Yang JY; Xia W; Chen CT; Xie X; Chao CH; Woodward WA; Hsu JM; Hortobagyi GN; Hung MC
    Cancer Cell; 2011 Jan; 19(1):86-100. PubMed ID: 21215703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
    Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
    J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia.
    D'Uva G; Bertoni S; Lauriola M; De Carolis S; Pacilli A; D'Anello L; Santini D; Taffurelli M; Ceccarelli C; Yarden Y; Montanaro L; Bonafé M; Storci G
    PLoS One; 2013; 8(11):e80742. PubMed ID: 24260469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.
    Storci G; Sansone P; Trere D; Tavolari S; Taffurelli M; Ceccarelli C; Guarnieri T; Paterini P; Pariali M; Montanaro L; Santini D; Chieco P; Bonafé M
    J Pathol; 2008 Jan; 214(1):25-37. PubMed ID: 17973239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
    Sansone P; Storci G; Tavolari S; Guarnieri T; Giovannini C; Taffurelli M; Ceccarelli C; Santini D; Paterini P; Marcu KB; Chieco P; Bonafè M
    J Clin Invest; 2007 Dec; 117(12):3988-4002. PubMed ID: 18060036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-catenin signaling pathway and the tolerance of breast cancer cells to hypoxic conditions.
    Scherbakov AM; Stefanova LB; Yakushina IA; Krasilnikov MA
    Klin Lab Diagn; 2013 Oct; (10):68-70, 37-40. PubMed ID: 24640101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
    Scherbakov AM; Stefanova LB; Sorokin DV; Semina SE; Berstein LM; Krasil'nikov MA
    Exp Cell Res; 2013 Dec; 319(20):3150-9. PubMed ID: 23973669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
    Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
    Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.
    Papi A; De Carolis S; Bertoni S; Storci G; Sceberras V; Santini D; Ceccarelli C; Taffurelli M; Orlandi M; Bonafé M
    J Cell Physiol; 2014 Nov; 229(11):1595-606. PubMed ID: 24604522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.
    Papi A; Storci G; Guarnieri T; De Carolis S; Bertoni S; Avenia N; Sanguinetti A; Sidoni A; Santini D; Ceccarelli C; Taffurelli M; Orlandi M; Bonafé M
    PLoS One; 2013; 8(1):e54968. PubMed ID: 23372804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
    Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
    Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
    Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 19
    Saha SK; Kim K; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.
    Chen K; Liu Q; Tsang LL; Ye Q; Chan HC; Sun Y; Jiang X
    Cell Death Dis; 2017 May; 8(5):e2819. PubMed ID: 28542126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 involvement in epithelial cancers.
    Schafer ZT; Brugge JS
    J Clin Invest; 2007 Dec; 117(12):3660-3. PubMed ID: 18060028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.